FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry, and can be applied for correction of malfunctions in immune system in case of pathological conditions, associated with insufficiency of Th 1 - dependent type of immune response. As immunomodulating medication, which stimulates Th 1 - dependent type of immune response, applied are water-soluble polysaccarides with molecular weight 540 and 390 kDa, separated from pharmacopeial raw material of elecampane.
EFFECT: medication extends arsenal of immunomodulating medications of vegetable origin, stimulates production of microphages of interleukin-12 and tumour necrosis factor-alpha.
4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOMODULATORY DRUG | 2010 |
|
RU2421232C1 |
IMMUNOMODULATORY DRUG | 2011 |
|
RU2470656C1 |
MEANS OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2657819C1 |
AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2018 |
|
RU2697526C1 |
AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2019 |
|
RU2734420C1 |
AGENT OF IMMUNOMODULATING ACTIVITY | 2007 |
|
RU2329821C1 |
AGENT OF HUMIC NATURE OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2662094C1 |
AGENT OF IMMUNOMODULATING ACTIVITY | 2007 |
|
RU2337700C1 |
IMMUNOMODULATING HUMIC AGENT | 2020 |
|
RU2756353C1 |
ANTIALLERGIC PREPARATION | 2008 |
|
RU2379047C1 |
Authors
Dates
2011-07-10—Published
2010-06-07—Filed